Integra LifeSciences names leader of Spine and Extremities businesses

By

Integra LifeSciences Announces Changes Within Its Orthopedics and Tissue Technologies Business (press release)
Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that Mark Augusti has joined Integra as CVP, President, Orthopedics and Tissue Technologies. Mr. Augusti will be responsible for the management of our Spine and Extremities divisions, including strategic direction, portfolio management and evaluation of corporate development opportunities.
"I am pleased that Mark has become a member of our team," said Mr. Arduini, Integra's President and Chief Executive Officer. "...

Get access to full posts newsletters, trends, and market reports for only subscribe for $1/day.
Hit the SUBSCRIBE button at the top of the homepage.